Human donor kidneys are in short supply. A new experiment that tested gene-edited organ transplants in monkeys showed that pig kidneys may one day be viable substitutes.
Kidneys remove waste, produce urine, and balance fluids in the body. In the United States alone, nearly 88,000 people are waiting for a kidney donation, according to data from the federal Organ Procurement and Transplantation Network. In 2022, only about 26,000 received one. When the kidneys stop working, people need to go on a dialysis machine to remove excess fluids and water from the blood. Once on dialysis, around half of patients die within five years.
Although these viruses have been shown to infect human cells in the lab, the health risks to actual patients is still theoretical. “The field has been torn between whether this is an issue or not,” says George Church, a geneticist at Harvard University and cofounder of eGenesis. “We just decided it was easier to address the issue than take a chance,” he said, so they eliminated those viruses with Crispr.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New guidance ties together heart disease, obesity, and kidney problemsGabrielle M. Etzel is the healthcare policy reporter for the Washington Examiner. Prior to joining the Washington Examiner, she served as a staff reporter at Campus Reform and as a freelance writer. After graduating from Grove City College, Etzel earned her master's in public policy and administration from Baylor University, where she conducted research on domestic sex trafficking. In her free time, Etzel enjoys being with her family in Pittsburgh, Pennsylvania.
Read more »
Police capture a cheeky monkey that escaped and went on the lamDonors will be given free tickets for the Spurs game on October 16, along with a Halloween Boo Crew t-shirt, in exchange for donating blood.
Read more »
Roundup herbicide ingredient connected to epidemic levels of chronic kidney diseaseFor the past couple of decades, tens of thousands of people living in rural Sri Lanka have been devastated by kidney failure due to unclear causes, also known as CKDu. Similar incidences of mysterious kidney diseases have emerged in tropical farming communities around the world.
Read more »
Dialysis-company stocks slide after Ozempic trial's success in treating kidney diseaseDaVita’s stock was down 16%, while Baxter and Intuitive Surgical were down 9% and 6%
Read more »
Ozempic Kidney Trial Stopped Due to Early SuccessNovo Nordisk said on Tuesday it will stop a trial studying Ozempic to treat kidney failure in diabetes patients ahead of schedule because it was clear from an interim analysis that the treatment would succeed. Novo said the trial would be halted almost a year early based on...
Read more »
Dialysis company shares plunge after Ozempic trial success vs. kidney troubleSteven Goldstein is based in London and responsible for MarketWatch's coverage of financial markets in Europe, with a particular focus on global macro and commodities. Previously, he was Washington bureau chief, directing MarketWatch's economic, political and regulatory coverage. Follow Steve on Twitter: MKTWgoldstein.
Read more »